Myrica nagi
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Myrica nagi |
|---|---|
| Database Name | cmaup_plants;imppat_herbs;osadhi_herbs |
| Tropicos | http://www.tropicos.org/Name/21700005 |
| Pow | http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:927488-1 |
| Mpns Kew | https://mpns.science.kew.org/mpns-portal/plantDetail?plantId=500812&query=Myrica+nagi&filter=&fuzzy=false&nameType=all&dbs=wcsCmp |
| Synonyms | Myrica nagi, Myrica Nagi |
| Ipni Id | http://www.ipni.org/ipni/idPlantNameSearch.do?id=927488-1&back_page=%2Fipni%2FeditSimplePlantNameSearch.do%3Ffind_wholeName%3DMyrica%2Bnagi%26output_format%3Dnormal, NPO5234 |
| Plant List Id | http://www.theplantlist.org/tpl1.1/record/kew-2500812 |
| Plant Name | Myrica nagi |
| Genus Tax Id | 3509 |
| Wfo | http://www.worldfloraonline.org/taxon/wfo-0000447458 |
| Frlht Plant Info | http://envis.frlht.org/plantdetails/3ade12e59b711b10949eec6066510d15/8fa1e898b8449bcf2e2142661a6336a4 |
| Disease Name | Irritable bowel syndrome, Parkinsonism, Alzheimer disease, Substance abuse, Stomach cancer, Myasthenia gravis, Diabetes mellitus, type unspecified, Oesophageal/gastroduodenal disorder, Pancreatic cancer, Bacterial infection, Brain cancer, Genetic prion disease, Influenza, Rheumatoid arthritis, Solid tumour/cancer, Type 2 diabetes mellitus, Lung cancer, Parasitic worm infestation, Coronavirus infection, Lupus erythematosus, Indeterminate colitis, Retinopathy, Bladder cancer, Acute myeloid leukaemia, Breast cancer, Ocular cancer, Kaposi sarcoma, Fungal infection, Liver cancer, Anogenital warts, Mild neurocognitive disorder, Pain, unspecified, Urinary tract infection, Skin and skin-structure infection, Otitis media, Syphilis, Multiple sclerosis, Glaucoma, Atopic eczema, Colorectal cancer, Malignant haematopoietic neoplasm, Respiratory system disease, HIV-infected patients with tuberculosis, Common warts, Mature B-cell lymphoma, Dementia, Acute/subacute hepatic failure, Colon cancer, Gonococcal infection, Ovarian cancer, Pediculosis, Muscular dystrophy, Parasitic infection, Choreiform disorder, Thrombosis, Unspecific substance harmful effect, Follicular lymphoma, Chemoprotection, Autonomic nervous system disorder, Mature T-cell lymphoma, Asthma, Psoriasis, Otitis externa, Diffuse large B-cell lymphoma, Becker muscular dystrophy, Pulmonary hypertension, Carcinosarcoma of uterus, Crohn disease, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Zika virus disease, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Adenocarcinoma of stomach, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Other specified malignant neoplasms ofcolon, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Chronic rhinosinusitis, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Ebola virus disease, Malignant neoplasms of adrenal gland |
| Species Name | Myrica nagi |
| System Of Medicine | Ayurveda, Siddha, Sowa Rigpa, Unani |
| Genus Name | Myrica |
| Species Tax Id | 262756 |
| Disease Id | DD91, 8A00, 8A20, 6C40, 2B72, 8C6Y, 5A14, DD90, 2C10, 1A00-1C4Z, 2A00, 8.00E+02, 1E30-1E32, FA20, 2A00-2F9Z, 5A11, 2C25, 1F90, 1D92, 4A40, DD72, 9B71, 2C94, 2A60, 2C60-2C6Y, 2D00-2D07, 2B57, 1F29-1F2F, 2C12, 1A95, 6D71, MG3Z, GC08, 1F28-1G0Z, AA80-AB0Z, 1A61-1A6Z, 8A40, 9C61, EA80, 2B91, 2B33, CB40-CB7Z, 1B10-1B14, 1.00E+80, 2A85, 6D80-6D8Z, DB91, 2B90, 1A70-1A7Z, 2C73, 1G00, 8C70, 1D0Y-1G2Z, 8A01, DB61-GB90, NE6Z, 2A80, N.A., 8D87, 2A90, CA23, EA90, AA00-AA13, 2A81, 8C70.0, BB01, 2C76.43, DD70, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, 1D48, FA0Z, 2C15, 2C12.01, 1F54, 2B72.0, 8C71.0, 2C90.Y, 2C25.2, 1D46, 2C10.0, 2C26.0, 2B90.Y, 2C12.02, 2C25.Y, GA10.B4, 2B70, 2C94.2, 1D82, CA0A, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 2C27, 2C61, BD1Z, 2A00.00, XH6153, 2C80.2, 8C10.0, 1D60.01, 2D11 |
| Family Name | Myricaceae |
| Family Tax Id | 26766 |
| Group | Angiosperms |
- 1. (+/-)-Epicatechin (PubChem CID: 255538)
- 2. (1r,2r,3s,7r,9r,10r,12r)-3,10-Dihydroxy-2-(Hydroxymethyl)-1,5-Dimethylspiro[8-Oxatricyclo[7.2.1.02,7]dodec-5-Ene-12,2'-Oxirane]-4-One (PubChem CID: 442408)
- 3. (1r,4r)-5,6-Dihydroxy-1-Methoxy-4,8,8-Trimethyl-1,4,9,10-Tetrahydropyrano[4,3-F]chromen-2-One (PubChem CID: 163073372)
- 4. (1s,2r,4s,5r,6r,9r,17r)-12-Ethyl-5-Hydroxy-1,6-Dimethyl-3,8,13-Trioxapentacyclo[7.7.1.02,4.06,17.011,16]heptadeca-11,15-Diene-7,14-Dione (PubChem CID: 162953302)
- 5. (1s,2r,4s,5r,6r,9s,10r,17r)-5,10-Dihydroxy-1,6-Dimethyl-12-Propan-2-Yl-3,8,13-Trioxapentacyclo[7.7.1.02,4.06,17.011,16]heptadeca-11,15-Diene-7,14-Dione (PubChem CID: 442063)
- 6. (1s,2r,4s,5s,10s,14s,17r)-5-Hydroxy-10,14-Dimethyl-3,6,16-Trioxapentacyclo[8.6.1.02,4.04,9.014,17]heptadec-8-Ene-7,15-Dione (PubChem CID: 9817995)
- 7. (1s,2r,5s,6s,9r,10r,17s)-5,10-Dihydroxy-1,6-Dimethyl-12-Propan-2-Yl-3,8,13-Trioxapentacyclo[7.7.1.02,4.06,17.011,16]heptadeca-11,15-Diene-7,14-Dione (PubChem CID: 6713066)
- 8. (1s,8r,9s,12s,14r,15s)-8,14,15-Trihydroxy-1,12-Dimethyl-6-Propan-2-Yl-5,10-Dioxatetracyclo[7.6.1.02,7.012,16]hexadeca-2,6-Diene-4,11-Dione (PubChem CID: 12004631)
- 9. (1s,8r,9s,12s,15r)-8,15-Dihydroxy-1,12-Dimethyl-6-Propan-2-Yl-5,10-Dioxatetracyclo[7.6.1.02,7.012,16]hexadeca-2,6-Diene-4,11-Dione (PubChem CID: 12004531)
- 10. (1s,9r,12s,16r)-1,12-Dimethyl-5,10-Dioxatetracyclo[7.6.1.02,7.012,16]hexadeca-2,7-Diene-4,11-Dione (PubChem CID: 9882005)
- 11. (2e,4e,6e)-N-Isobutyl-7-(2-Thienyl)-2,4,6-Heptatrienamide (PubChem CID: 73349612)
- 12. (2e,4e,6e)-N-Isopentyl-7-(2-Thienyl)-2,4,6-Heptatrienamide (PubChem CID: 72696080)
- 13. (3r)-4,5-Dihydroxy-3,7,7-Trimethyl-8,9-Dihydro-3h-Furo[3,4-F]chromen-1-One (PubChem CID: 162983137)
- 14. (4r)-5-Hydroxy-4,8,8-Trimethyl-9,10-Dihydro-4h-Pyrano[4,3-F]chromene-2,6-Dione (PubChem CID: 91617751)
- 15. (6r,9s)-Vomifoliol (PubChem CID: 11816951)
- 16. 2,4-Dodecadienamide, N-(2-Methylpropyl)-, (2e,4e)- (PubChem CID: 6443006)
- 17. 21-Hydroxypregna-4,6-Diene-3,12,20-Trione (PubChem CID: 16104852)
- 18. 5-Methoxycanthin-6-One (PubChem CID: 259218)
- 19. [(3s,5s,8r,9s,10s,13r,14s,16s,17r)-14-Hydroxy-3-[(2r,4r,5s,6r)-5-Hydroxy-4-Methoxy-6-Methyloxan-2-Yl]oxy-10,13-Dimethyl-17-(5-Oxo-2h-Furan-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-16-Yl] Acetate (PubChem CID: 16756310)
- 20. Beta-Sitosterol (PubChem CID: 222284)
- 21. Bredemolic Acid (PubChem CID: 3694932)
- 22. Bruceajavanin A (PubChem CID: 10030889)
- 23. Bruceajavanone A (PubChem CID: 44582338)
- 24. Bruceajavanone A 7-Acetate (PubChem CID: 44582339)
- 25. Bruceantin (PubChem CID: 5281304)
- 26. Bruceine A (PubChem CID: 160006)
- 27. Bruceine B (PubChem CID: 161496)
- 28. Bruceolline B (PubChem CID: 190940)
- 29. Cacticin (PubChem CID: 5318644)
- 30. Cid 161779 (PubChem CID: 161779)
- 31. Dehydrobruceine B (PubChem CID: 101967133)
- 32. Dehydrobrusatol (PubChem CID: 59087297)
- 33. Digitoxigenin (PubChem CID: 4369270)
- 34. Diosmetin (PubChem CID: 5281612)
- 35. Epicatechin (PubChem CID: 72276)
- 36. Flavylium (PubChem CID: 145858)
- 37. Flazin (PubChem CID: 5377686)
- 38. Hyperoside (PubChem CID: 5281643)
- 39. Juniper Camphor (PubChem CID: 5318734)
- 40. Jurubine (PubChem CID: 52931419)
- 41. Ll-Z 1271alpha (PubChem CID: 301929)
- 42. Medioresinol (PubChem CID: 181681)
- 43. Methyl (1r,2s,3r,6r,8s,11s,12s,13s,14r,15r,16s,17s)-12,15,16-Trihydroxy-9,13-Dimethyl-3-(3-Methylbutanoyloxy)-4-Oxo-11-[(2r,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-5,18-Dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-9-Ene-17-Carboxylate (PubChem CID: 101659162)
- 44. Methyl (1r,2s,3r,6r,8s,9s,13s,14r,15r,16s,17s)-15,16-Dihydroxy-3-(3-Hydroxy-3-Methylbutanoyl)oxy-9,13-Dimethyl-4,10-Dioxo-11-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-5,18-Dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-11-Ene-17-Carboxylate (PubChem CID: 101659163)
- 45. Myricadiol (PubChem CID: 3084282)
- 46. Myricanone (PubChem CID: 161748)
- 47. Myricetin (PubChem CID: 5281672)
- 48. Myricitrin (PubChem CID: 5281673)
- 49. Nagilactone A (PubChem CID: 3084328)
- 50. Nagilactone B (PubChem CID: 3084329)
- 51. Nagilactone G (PubChem CID: 71300384)
- 52. Neritaloside (PubChem CID: 44566654)
- 53. Oidiodendronic Acid (PubChem CID: 9860399)
- 54. Oidiolactone A (PubChem CID: 9948974)
- 55. Oleanderolide (PubChem CID: 11113483)
- 56. Oleandrigenin (PubChem CID: 9802865)
- 57. Oliveridine (PubChem CID: 13891891)
- 58. Picrasidine Q (PubChem CID: 54714262)
- 59. Podolactone B,2-Deepoxy-15,16-Dideoxy- (PubChem CID: 54607199)
- 60. Rutin (PubChem CID: 5280805)
- 61. Stearic Acid (PubChem CID: 5281)
- 62. Taraxerol (PubChem CID: 92097)
- 63. Totaradiol (PubChem CID: 9995105)
- 64. Ursolic Acid Acetate (PubChem CID: 6475119)
- 65. Vomifoliol, (+)- (PubChem CID: 5280462)
- 1. Alzheimer's Disease 1
- 2. Anemia
- 3. Arthritis, Rheumatoid
- 4. Asthma
- 5. Bronchitis
- 6. Celiac Disease
- 7. Chancre
- 8. Cholera
- 9. Common Cold
- 10. Common Wart
- 11. Crohn Disease
- 12. Dementia
- 13. Diabetes Mellitus
- 14. Dysentery
- 15. Epilepsy
- 16. Glaucoma
- 17. Gonorrhea
- 18. Hemorrhoids
- 19. Infertility
- 20. Inflammatory Bowel Diseases
- 21. Influenza, Human
- 22. Liver Neoplasms
- 23. Lung Diseases
- 24. Lupus Erythematosus, Systemic
- 25. Muscular Dystrophies
- 26. Osteoarthritis
- 27. Periodontal Diseases
- 28. Pharyngeal Diseases
- 29. Poliomyelitis
- 30. Psoriasis
- 31. Urinary Tract Infections
- 32. Uterine Diseases
Not listed in any formulations.